Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Does neuroimaging have a role in predicting outcomes in psychosis?

McGuire P, Dazzan P.

World Psychiatry. 2017 Jun;16(2):209-210. doi: 10.1002/wps.20426. No abstract available.

2.

Aerobic Exercise in People with Schizophrenia: Neural and Neurocognitive Benefits.

Vakhrusheva J, Marino B, Stroup TS, Kimhy D.

Curr Behav Neurosci Rep. 2016 Jun;3(2):165-175. Epub 2016 Apr 4.

3.

Multi-center MRI prediction models: Predicting sex and illness course in first episode psychosis patients.

Nieuwenhuis M, Schnack HG, van Haren NE, Lappin J, Morgan C, Reinders AA, Gutierrez-Tordesillas D, Roiz-Santiañez R, Schaufelberger MS, Rosa PG, Zanetti MV, Busatto GF, Crespo-Facorro B, McGorry PD, Velakoulis D, Pantelis C, Wood SJ, Kahn RS, Mourao-Miranda J, Dazzan P.

Neuroimage. 2017 Jan 15;145(Pt B):246-253. doi: 10.1016/j.neuroimage.2016.07.027. Epub 2016 Jul 12.

4.

Neurocognition and Duration of Psychosis: A 10-year Follow-up of First-Episode Patients.

Rund BR, Barder HE, Evensen J, Haahr U, ten Velden Hegelstad W, Joa I, Johannessen JO, Langeveld J, Larsen TK, Melle I, Opjordsmoen S, Røssberg JI, Simonsen E, Sundet K, Vaglum P, McGlashan T, Friis S.

Schizophr Bull. 2016 Jan;42(1):87-95. doi: 10.1093/schbul/sbv083. Epub 2015 Jun 21.

5.

The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial.

Lisiecka DM, Suckling J, Barnes TR, Chaudhry IB, Dazzan P, Husain N, Jones PB, Joyce EM, Lawrie SM, Upthegrove R, Deakin B.

Trials. 2015 Mar 2;16:71. doi: 10.1186/s13063-015-0580-x.

6.

Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment.

Ahmed M, Cannon DM, Scanlon C, Holleran L, Schmidt H, McFarland J, Langan C, McCarthy P, Barker GJ, Hallahan B, McDonald C.

Neuropsychopharmacology. 2015 Sep;40(10):2409-17. doi: 10.1038/npp.2015.90. Epub 2015 Apr 1.

7.

Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research.

Dazzan P, Arango C, Fleischacker W, Galderisi S, Glenthøj B, Leucht S, Meyer-Lindenberg A, Kahn R, Rujescu D, Sommer I, Winter I, McGuire P.

Schizophr Bull. 2015 May;41(3):574-83. doi: 10.1093/schbul/sbv024. Epub 2015 Mar 23. Review.

8.

How can neuroimaging facilitate the diagnosis and stratification of patients with psychosis?

Kempton MJ, McGuire P.

Eur Neuropsychopharmacol. 2015 May;25(5):725-32. doi: 10.1016/j.euroneuro.2014.07.006. Epub 2014 Jul 20. Review.

9.

Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis.

Ansell BR, Dwyer DB, Wood SJ, Bora E, Brewer WJ, Proffitt TM, Velakoulis D, McGorry PD, Pantelis C.

Psychol Med. 2015 Feb;45(3):515-27. doi: 10.1017/S0033291714001652. Epub 2014 Jul 31.

10.

The neurobiology and treatment of first-episode schizophrenia.

Kahn RS, Sommer IE.

Mol Psychiatry. 2015 Feb;20(1):84-97. doi: 10.1038/mp.2014.66. Epub 2014 Jul 22. Review.

11.

The Course and Correlates of Everyday Functioning in Schizophrenia.

Reichenberg A, Feo C, Prestia D, Bowie CR, Patterson TL, Harvey PD.

Schizophr Res Cogn. 2014 Mar 1;1(1):e47-e52.

13.

Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

Fusar-Poli P, Smieskova R, Kempton MJ, Ho BC, Andreasen NC, Borgwardt S.

Neurosci Biobehav Rev. 2013 Sep;37(8):1680-91. doi: 10.1016/j.neubiorev.2013.06.001. Epub 2013 Jun 14.

14.

Hospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophrenia.

Harvey PD, Loewenstein DA, Czaja SJ.

Neurobiol Dis. 2013 May;53:18-25. doi: 10.1016/j.nbd.2012.10.022. Epub 2012 Oct 31. Review.

15.

Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia.

Sliwa JK, Bossie CA, Fu DJ, Turkoz I, Alphs L.

Neuropsychiatr Dis Treat. 2012;8:375-85. doi: 10.2147/NDT.S32581. Epub 2012 Aug 27.

16.

Intact relational memory and normal hippocampal structure in the early stage of psychosis.

Williams LE, Avery SN, Woolard AA, Heckers S.

Biol Psychiatry. 2012 Jan 15;71(2):105-13. doi: 10.1016/j.biopsych.2011.09.016. Epub 2011 Nov 4.

17.

Is there evidence for neurotoxicity in the prodromal and early stages of schizophrenia?

Lahti AC, Reid MA.

Neuropsychopharmacology. 2011 Aug;36(9):1779-80. doi: 10.1038/npp.2011.83. No abstract available.

18.

The effect of five years versus two years of specialised assertive intervention for first episode psychosis - OPUS II: study protocol for a randomized controlled trial.

Melau M, Jeppesen P, Thorup A, Bertelsen M, Petersen L, Gluud C, Krarup G, Nordentoft M.

Trials. 2011 Mar 10;12:72. doi: 10.1186/1745-6215-12-72.

19.

The contributions of disease and genetic factors towards regional cortical thinning in schizophrenia: the UCLA family study.

Yang Y, Nuechterlein KH, Phillips O, Hamilton LS, Subotnik KL, Asarnow RF, Toga AW, Narr KL.

Schizophr Res. 2010 Nov;123(2-3):116-25. doi: 10.1016/j.schres.2010.08.005.

20.

IQ trajectory, cognitive reserve, and clinical outcome following a first episode of psychosis: a 3-year longitudinal study.

Leeson VC, Sharma P, Harrison M, Ron MA, Barnes TR, Joyce EM.

Schizophr Bull. 2011 Jul;37(4):768-77. doi: 10.1093/schbul/sbp143. Epub 2009 Nov 24.

Supplemental Content

Support Center